Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 4/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | KIF11 | P52732 | 2/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | LTA4H | P09960 | 1/20 | 0.32 |
| ▸ | EDNRB | P24530 | 1/20 | 0.32 |
| ▸ | EDNRA | P25101 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5962153 | 0.83 | KCNN4 (0.40) | KCNN4MAPK1KIF11TAAR1ALDH1A1 | |
| SCHEMBL7606440 | 0.79 | KCNN4 (0.38) | KCNN4MAPK1KIF11TAAR1ALDH1A1 | |
| SCHEMBL3891423 | 0.79 | KCNN4 (0.38) | KCNN4MAPK1KIF11TAAR1ALDH1A1 | |
| SCHEMBL4058230 | 0.79 | TAAR1 (0.48) | KCNN4MAPK1KIF11TAAR1 | |
| SCHEMBL16144806 | 0.78 | KCNN4 (0.42) | KCNN4MAPK1KIF11TAAR1ALDH1A1 | |
| SCHEMBL3663149 | 0.78 | CYP1A2 (0.45) | KCNN4KIF11TAAR1ALDH1A1CYP3A4 | |
| SCHEMBL28893285 | 0.78 | MAPK1 (0.40) | KCNN4MAPK1KIF11TAAR1ALDH1A1 | |
| SCHEMBL3933085 | 0.78 | KCNN4 (0.38) | KCNN4MAPK1KIF11TAAR1ALDH1A1 | |
| SCHEMBL6755985 | 0.75 | LTA4H (0.37) | KCNN4KIF11CYP3A4CYP2D6CHRM2 | |
| SCHEMBL27665132 | 0.75 | CYP2C19 (0.53) | KCNN4ALDH1A1CYP3A4CYP2D6LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9216952-B2 | Process for preparing antiviral compound | ABBVIE INC. (US) | 2015-12-22 | — | — | US | claimed |
| US-9181399-B2 | Method for producing polysiloxane | TOAGOSEI CO., LTD. (JP) | 2015-11-10 | — | — | US | claimed |
| US-20140303392-A1 | METHOD FOR PRODUCING POLYSILOXANE | TOAGOSEI CO., LTD. (JP) | 2014-10-09 | — | — | US | claimed |
| EP-2411372-B1 | PROCESS FOR PREPARING AN ANTIVIRAL COMPOUND | ABBVIE BAHAMAS LTD (BS) | 2014-07-23 | — | — | EP | claimed |
| EP-2411372-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUND | Abbott Laboratories (US) | 2012-02-01 | — | — | EP | claimed |
| US-20110237793-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUND | ABBOTT LABORATORIES (US) | 2011-09-29 | — | — | US | claimed |
| WO-2010111348-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUND | ABBOTT LABORATORIES (US) | 2010-09-30 | — | — | WO | claimed |
| US-20240158904-A1 | UNDERCOAT AGENT COMPOSITION FOR LAYERING INORGANIC MATERIAL LAYER, CURED PRODUCT THEREOF AND PRODUCTION METHOD THEREOF | TOAGOSEI CO., LTD. (JP) | 2024-05-16 | — | — | US | disclosed |
| US-11981828-B2 | Water repellent and oil repellent film composition and use thereof | TOAGOSEI CO. LTD. (JP) | 2024-05-14 | — | — | US | disclosed |
| CN-115103872-B | Silsesquioxane derivative and use thereof | 东亚合成株式会社 | 2024-02-02 | — | — | CN | disclosed |
| EP-4289618-A1 | UNDERCOAT AGENT COMPOSITION FOR INORGANIC SUBSTANCE LAYER LAMINATION, CURED PRODUCT THEREOF, AND METHOD FOR PRODUCING SAME | Toagosei Co., Ltd. (JP) | 2023-12-13 | — | — | EP | disclosed |
| CN-112888715-B | Silsesquioxane derivative composition and use thereof | 东亚合成株式会社 | 2023-11-03 | — | — | CN | disclosed |
| CN-116897195-A | Primer composition for inorganic substance layer lamination, cured product thereof, and method for producing same | 东亚合成株式会社 | 2023-10-17 | — | — | CN | disclosed |
| US-9216952-B2 | Process for preparing antiviral compound | ABBVIE INC. (US) | 2015-12-22 | — | — | US | disclosed |
| US-9181399-B2 | Method for producing polysiloxane | TOAGOSEI CO., LTD. (JP) | 2015-11-10 | — | — | US | disclosed |
| US-20140303392-A1 | METHOD FOR PRODUCING POLYSILOXANE | TOAGOSEI CO., LTD. (JP) | 2014-10-09 | — | — | US | disclosed |
| EP-2411372-B1 | PROCESS FOR PREPARING AN ANTIVIRAL COMPOUND | ABBVIE BAHAMAS LTD (BS) | 2014-07-23 | — | — | EP | disclosed |
| EP-2411372-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUND | Abbott Laboratories (US) | 2012-02-01 | — | — | EP | disclosed |
| US-20110237793-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUND | ABBOTT LABORATORIES (US) | 2011-09-29 | — | — | US | disclosed |
| WO-2010111348-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUND | ABBOTT LABORATORIES (US) | 2010-09-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110237793-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUND | ZC3HAV1, HAVCR2, MAVS | KCNN4 4562/4885MAPK1 2356/4885KIF11 2064/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.